AA
BTX.WS

Apriem Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Apriem Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14
Closed – – 634
2017
Q1 		$0 Hold
14
– – ﹤0.01% 752
2016
Q4 		$0 Hold
14
– – ﹤0.01% 757
2016
Q3 		$0 Hold
14
– – ﹤0.01% 664
2016
Q2 		$0 Hold
14
– – ﹤0.01% 664
2016
Q1 		$0 Hold
14
– – ﹤0.01% 647
2015
Q4 		$0 Hold
14
– – ﹤0.01% 585
2015
Q3 		$0 Hold
14
– – ﹤0.01% 641
2015
Q2 		$0 Hold
14
– – ﹤0.01% 704
2015
Q1 		$0 Hold
14
– – ﹤0.01% 605
2014
Q4 		$0 Buy
+14
New +$15 ﹤0.01% 572

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Apriem Advisors's BTX.WS Position: Q2 2017 in Review

Apriem Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q2 2017, closing a stake of 14 shares.

Apriem Advisors first reported a position in BTX.WS in Q4 2014 and held it in 10 quarters. The position peaked at $0 in Q1 2017. 35 funds tracked by Wall St. Rank hold BTX.WS as of Q2 2017.

  • Apriem Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 14 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q2 2017.
  • Apriem Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 10 quarters.
  • Apriem Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q1 2017.
  • 35 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.